Base4

About:

A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology.

Top Investors: Amadeus Capital Partners, Longwall Venture, Oxford Technology Management, Royal Society Enterprise Fund, Meridian Growth Capital

Description:

Base4 is focused on the innovation and development of state-of-the-art technologies for single-molecule analysis. We are developing cutting-edge, high-value technologies with demonstrable technical and commercial feasibility while building a valuable portfolio of IP and know-how.

Total Funding Amount:

22.5M GBP

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2007-01-01

Contact Email:

info(AT)base4.co.uk

Founders:

Barnaby Balmforth, Cameron Frayling, Nicholas Pilkington

Number of Employees:

11-50

Last Funding Date:

2019-04-15

IPO Status:

Private

Industries: